(Q46941197)

26 December 2017

title

TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease (English)

1 reference

26 December 2017

11

Deborah Nickerson

1 reference

26 December 2017

Thomas S Hatsukami

3

object named as

Thomas S Hatsukami

1 reference

26 December 2017

author name string

Christopher S Carlson

1

1 reference

26 December 2017

Patrick J Heagerty

2

1 reference

26 December 2017

Rebecca J Richter

4

1 reference

26 December 2017

Jane Ranchalis

5

1 reference

26 December 2017

Julieann Lewis

6

1 reference

26 December 2017

Tamara J Bacus

7

1 reference

26 December 2017

Laura A McKinstry

8

1 reference

26 December 2017

Gerard D Schellenberg

9

1 reference

26 December 2017

Mark Rieder

10

1 reference

26 December 2017

Clement E Furlong

12

1 reference

26 December 2017

Alan Chait

13

1 reference

26 December 2017

Gail P Jarvik

14

1 reference

26 December 2017

language of work or name

1 reference

11 February 2006

1 reference

26 December 2017

Journal of Lipid Research

published in

1 reference

26 December 2017

volume

47

1 reference

26 December 2017

page(s)

1014-1024

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

Serum paraoxonase after myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia Is the Result of Their Increased Cellular Cholesterol Content: Effect of Atorvastatin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Evidence for non-additive influence of single nucleotide polymorphisms within the apolipoprotein E gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Ex vivo measures of LDL oxidative susceptibility predict carotid artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Highly parallel SNP genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

The molecular basis of the human serum paraoxonase activity polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Polymorphisms in the human paraoxonase (PON1) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Haplotype-phenotype relationships of paraoxonase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500517-JLR200

10.1194/JLR.M500517-JLR200

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16474172

1 reference

26 December 2017